Facebook Pixel

FDA Approves Reclast Use Once Every Two Years

Rate This

Reclast has received U.S. approval as an osteoporosis treatment that can be used once every two years, drug maker Novartis AG announced Monday.

The Associated Press reported that the drug was already being used in the U.S. and Europe as a once-a-year infusion therapy to treat postmenopausal osteoporosis in women, to increase bone mass in men with osteoporosis, and to treat and prevent osteoporosis caused by steroid treatment.

The U.S. Food and Drug Administration approval for use of Reclast once every two years is based on research involving more than 500 post-menopausal women with low bone mass, Novartis said. A single infusion of the drug significantly increased bone mineral density at two years, the study found.

According to Novartis, osteoporosis affects about 10 million women and men in the United States, the AP reported.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy


Get Email Updates

Osteoporosis Guide


Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!